LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | BI-2536 | 0.37 | uM | LJP6 | 72 | hr | 868 | 1170 | 3486 | 0.3358 | 0.1156 |
MDA-MB-231 | BMS345541 | 0.37 | uM | LJP6 | 72 | hr | 868 | 3262 | 3486 | 0.9356 | 0.9143 |
MDA-MB-231 | SNS-032 | 0.37 | uM | LJP6 | 72 | hr | 868 | 771 | 3486 | 0.2213 | -0.0368 |
MDA-MB-231 | GDC-0980 | 0.37 | uM | LJP5 | 72 | hr | 868 | 1880 | 3486 | 0.5393 | 0.3866 |
MDA-MB-231 | NVP-AEW541 | 0.37 | uM | LJP5 | 72 | hr | 868 | 3583 | 3486 | 1.0277 | 1.0369 |
MDA-MB-231 | SB590885 | 0.37 | uM | LJP5 | 72 | hr | 868 | 2772 | 3486 | 0.7951 | 0.7272 |
MDA-MB-231 | PIK-93 | 0.37 | uM | LJP5 | 72 | hr | 868 | 3735 | 3486 | 1.0715 | 1.0952 |
MDA-MB-231 | KIN001-043 | 0.37 | uM | LJP6 | 72 | hr | 868 | 3030 | 3486 | 0.8693 | 0.8259 |
MDA-MB-231 | Alpelisib | 0.37 | uM | LJP5 | 72 | hr | 868 | 3413 | 3486 | 0.9790 | 0.9720 |
MDA-MB-231 | Luminespib | 0.37 | uM | LJP5 | 72 | hr | 868 | 1067 | 3486 | 0.3061 | 0.0760 |
MDA-MB-231 | A443654 | 0.37 | uM | LJP6 | 72 | hr | 868 | 859 | 3486 | 0.2464 | -0.0035 |
MDA-MB-231 | OSI-027 | 0.37 | uM | LJP6 | 72 | hr | 868 | 2835 | 3486 | 0.8133 | 0.7513 |
MDA-MB-231 | XMD11-85h | 0.37 | uM | LJP6 | 72 | hr | 868 | 2817 | 3486 | 0.8080 | 0.7443 |
MDA-MB-231 | HG-6-64-01 | 0.37 | uM | LJP6 | 72 | hr | 868 | 2755 | 3486 | 0.7902 | 0.7207 |
MDA-MB-231 | WH-4-025 | 0.37 | uM | LJP5 | 72 | hr | 868 | 1345 | 3486 | 0.3858 | 0.1821 |
MDA-MB-231 | WZ-4-145 | 0.37 | uM | LJP6 | 72 | hr | 868 | 2918 | 3486 | 0.8371 | 0.7830 |
MDA-MB-231 | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 868 | 1224 | 3486 | 0.3513 | 0.1362 |
MDA-MB-231 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 868 | 2967 | 3486 | 0.8512 | 0.8019 |
MDA-MB-231 | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 868 | 2791 | 3486 | 0.8005 | 0.7344 |
MDA-MB-231 | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 868 | 2960 | 3486 | 0.8491 | 0.7991 |
MDA-MB-231 | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 868 | 3162 | 3486 | 0.9071 | 0.8762 |
MDA-MB-231 | Celastrol | 0.37 | uM | LJP6 | 72 | hr | 868 | 2005 | 3486 | 0.5752 | 0.4343 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 868 | 695 | 3486 | 0.1995 | -0.0659 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 868 | 808 | 3486 | 0.2318 | -0.0230 |
MDA-MB-231 | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 868 | 2913 | 3486 | 0.8357 | 0.7813 |